Anti-EGFR Strategy for Colorectal Cancer: Searching for the Real Target

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|8|541-543

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.8, 2006-10, pp. : 541-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 68-79

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice

By Scartozzi Mario   Pierantoni Chiara   Berardi Rossana   Squadroni Michela   Cascinu Stefano  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 281-287

Informa Healthcare

Access to resources Recommend Favorite

Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 316-328

Bentham Science Publishers

Access to resources Recommend Favorite

KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 813-823

Bentham Science Publishers

Access to resources Recommend Favorite